Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis. [electronic resource]
Producer: 20200909Description: 661-667 p. digitalISSN:- 1473-5687
- Adalimumab -- therapeutic use
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Colitis, Ulcerative -- drug therapy
- Comparative Effectiveness Research
- Female
- Gastrointestinal Agents -- therapeutic use
- Glucocorticoids -- therapeutic use
- Humans
- Infliximab -- therapeutic use
- Maintenance Chemotherapy
- Male
- Middle Aged
- Remission Induction
- Retrospective Studies
- Treatment Outcome
- Tumor Necrosis Factor Inhibitors -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.